A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

A Stanford-led study published in Nature on Feb. 26 found that age-related changes witnessed in diseases like Alzheimer’s may be related to a relatively untapped area of research in the brain. The ...

Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...

The seven-year medical odyssey that once defined rare disease diagnosis is being rewritten by algorithms capable of identifying medical zebras in the time it takes to refresh your social media feed.

In the study The Shadow and the Self in Digital Twins in Healthcare as an AI Environment, published in AI & Society, researchers explore how digital twins may influence not only medical ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to identifying genetic perturbation patterns in cell images – potentially enabling ...